EC approves Jardiance from Boehringer, Lilly

The European Commission approved Jardiance empagliflozin from Boehringer Ingelheim GmbH (Ingelheim, Germany) and partner Eli Lilly and Co. (NYSE:LLY) as an adjunct to diet and exercise to improve glyc...